Drug Shortage Report for AMERGE
| Report ID | 2581 |
| Drug Identification Number | 02237821 |
| Brand name | AMERGE |
| Common or Proper name | Naratriptan hydrochloride tablet |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | NARATRIPTAN |
| Strength(s) | 2.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 6's |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-03-02 |
| Estimated end date | 2017-05-15 |
| Actual end date | 2017-05-11 |
| Shortage status | Resolved |
| Updated date | 2017-05-12 |
| Company comments | AMERGE® Tablet 1mg is available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2017-05-12 | French | Compare |
| v10 | 2017-05-12 | English | Compare |
| v9 | 2017-05-12 | English | Compare |
| v8 | 2017-05-10 | French | Compare |
| v7 | 2017-05-10 | English | Compare |
| v6 | 2017-03-24 | French | Compare |
| v5 | 2017-03-24 | English | Compare |
| v4 | 2017-03-22 | French | Compare |
| v3 | 2017-03-22 | English | Compare |
| v2 | 2017-03-14 | French | Compare |
| v1 | 2017-03-14 | English | Compare |
Showing 1 to 11 of 11